EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for CRL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 -4.852
March 31, 2026 -3.760
December 31, 2025 -2.956
September 30, 2025 -1.555
June 30, 2025 -1.325
March 31, 2025 -0.6501
December 31, 2024 0.2565
September 30, 2024 8.098
June 30, 2024 8.460
March 31, 2024 8.610
December 31, 2023 9.208
September 30, 2023 9.232
June 30, 2023 9.419
March 31, 2023 9.666
December 31, 2022 9.473
September 30, 2022 8.494
June 30, 2022 8.619
March 31, 2022 8.21
December 31, 2021 7.602
September 30, 2021 7.740
June 30, 2021 7.764
March 31, 2021 7.383
December 31, 2020 7.194
September 30, 2020 5.999
June 30, 2020 5.434
Date Value
March 31, 2020 4.972
December 31, 2019 5.071
September 30, 2019 4.672
June 30, 2019 4.432
March 31, 2019 4.646
December 31, 2018 4.609
September 30, 2018 2.767
June 30, 2018 2.628
March 31, 2018 2.649
December 31, 2017 2.541
September 30, 2017 4.100
June 30, 2017 3.806
March 31, 2017 3.42
December 31, 2016 3.23
September 30, 2016 2.97
June 30, 2016 2.97
March 31, 2016 3.26
December 31, 2015 3.14
September 30, 2015 3.04
June 30, 2015 2.93
March 31, 2015 2.65
December 31, 2014 2.66
September 30, 2014 2.49
June 30, 2014 2.45
March 31, 2014 2.27

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
IQVIA Holdings, Inc. 8.062
Medpace Holdings, Inc. 17.05
Fortrea Holdings, Inc. -0.9158
Avantor, Inc. -0.8468
Champions Oncology, Inc. -0.0812